Trials / Unknown
UnknownNCT02668146
An Efficacy/Safety Study of Perampanel for Reducing Essential Tremor
A Double-Blind, Cross-Over, Placebo-Controlled Efficacy and Tolerability Study of Perampanel and Essential Tremor
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- VA Greater Los Angeles Healthcare System · Federal
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Obtain information on whether the medication Perampanel reduces tremor in people with essential tremor and is well-tolerated.
Detailed description
Please see descriptions in "Primary and Secondary Outcomes".
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Perampanel | Study drug will be administered to study subjects |
| DRUG | Placebo | Placebo will be administered to study subjects |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2017-03-01
- Completion
- 2017-06-01
- First posted
- 2016-01-29
- Last updated
- 2016-09-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02668146. Inclusion in this directory is not an endorsement.